Global Corneal Implants Market is forecast to grow at a moderate CAGR during the forecast period. The key application of the corneal implants include optical, reconstructive, therapeutic and cosmetic. Corneal implants aid in an improvement of vision in cases of corneal oedema, pseudophakic bullous keratopathy, keratoconus, corneal degeneration, keratoglobus, and dystrophy, as well as scarring due to keratitis and trauma. The primary factors that contribute to the growth of the corneal implant market include an increase in eye disorders owing to pollution, consistent use of computers and mobiles, and so on. There are various factors which is expected to contribute in the growth of the market in the near future such as technological advancement in the optical sector for treatment. Introduction of novel and advanced devices that aids in the reduction of human errors along with the high prevalence of ophthalmic diseases, which in turn requires treatments, thus it is one of the major factors for the growth of the market.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/corneal-implants-market
Based on the geographic viewpoint, Asia-Pacific registered significant growth in the market attributed to the rise in the number of corneal transplants along with a large number of patients suffering from various eye diseases creates various growth opportunities for the key players of corneal implants market during forecast period. Furthermore, several programs for effectual eye-banking skills systematized by eye banks and other administrations likely provide growth to the Asia Pacific corneal implants industry growth over the forecast period.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/corneal-implants-market
Further, Bayer AG, Medtronic Plc, F. Hoffmann-La Roche Ltd., Pfizer Inc. Bausch & Lomb Inc., PowerVision Inc., Presbia PLC, and Regeneron Pharmaceuticals Inc., among others are the prominent players in the global corneal implants market. These are the key companies providing various solutions for the novel and advanced corneal implants. New product launches and approvals, merger and acquisition, partnerships and collaborations, and many others are the strategies adopted by corneal implants manufacturers the thrive in a competitive environment in the corneal implant market.
The Report Global Corneal Implants Market – Segmentation
By Tissue Type
- Artificial Cornea
- Human Donor
By Corneal Disease
- Fungal keratitis
- Fuchs Dystrophy
- Keratoconus
By End-User
- Hospitals
- Eye Clinics
- Ambulatory Surgical Centers (ASC)
The Report Corneal Implants Market – Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- AcuFocus, Inc.
- Addition Technology, Inc., (A Company of AJL Ophthalmic, S.A.)
- Adverum Biotechnologies Inc.
- Alcon (A Division of Novartis AG)
- Astellas Pharma US, Inc.
- Bausch & Lomb Inc.
- Bayer AG
- Boehringer Ingelheim GmbH
- Cornea Bioscience
- CryoLife Inc.
- Hoffmann-La Roche Ltd.
- Keramed Inc.
- Medtronic Plc
- Pfizer Inc.
- Presbia PLC
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
